BCYCBicycle Therapeutics plc American Depositary Shares
Identity
- Security key
- 12359
- Ticker
- BCYC
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2019-05-23
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- BCYC
Detail
Enriched 2026-08-14 20:47
- Market cap
- $284,171,056.26
- Shares outstanding (class)
- 50,554,927
- Shares outstanding (weighted)
- 69,992,871
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 288
- Location
- CAMBRIDGE, X0
- Description
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.